| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |